Leopoldo Spadea* and Andrea Iannaccone
Eye Clinic, Policlinico “Umberto I”, University “La Sapienza”, Rome, Italy
*Corresponding Author: Leopoldo Spadea, Associate Professor, Head of Eye Clinic, Policlinico “Umberto I”, University “La Sapienza”, Rome, Italy.
Received: November 24, 2020; Published: November 30, 2020
COVID-19 is a newly defined disease, affecting the respiratory system. It is caused by a novel coronavirus, called Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The growing importance of the outbreak led the World Health Organization (WHO) to declare it a public health emergency of international concern on 30 January 2020 and to later officially describe it as a pandemic on 11 March 2020 . Italy was the first European country to be heavily impacted by COVID-19, with the number of cases and deaths caused by the virus surging in the months of March and April 2020 . Ophthalmologists represent a high-risk category for the spread of the infection, mainly because the examination demands close contact with the patient, exposing the clinician to tear, conjunctival secretions and to aerosol droplets .
Citation: Leopoldo Spadea and Andrea Iannaccone. “COVID-19 and Ophthalmology Practice at University Hospital “Policlinico Umberto I” in Rome”. Acta Scientific Ophthalmology 4.1 (2021): 01-02.
Copyright: © 2021 Leopoldo Spadea and Andrea Iannaccone. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.